// company-profile

Denali Therapeutics Inc.

DNLI
ExchangeNasdaqSectorBiological Products, (No Diagnostic Substances)Inc.DEFilings119Insiders20
// api This Denali Therapeutics Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 18 insiders purchased shares. Buying was led by Cook Jennifer E..

// 90-day insight

Over the last 90 days, Denali Therapeutics Inc. insiders bought $0 across 18 transactions with no open-market sales.

  • Most active insider: BAKER BROS. ADVISORS LP with 4 transactions totaling $0.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of Denali Therapeutics Inc. as of 2026-03-31

↑ increasing
Total reported AUM
$2.47B
QoQ change
+18.4%
Reporting period
2026-03-31
#1
BAILLIE GIFFORD & CO
CIK 1088875
$143.9M
7.5M shares
#2
Temasek Holdings (Private) Ltd
CIK 1021944
$134.6M
7.0M shares
#3
BlackRock, Inc.
CIK 2012383
$123.1M
6.4M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 3, 2026Cook Jennifer E.DNLI
Award
19,226$0.00$0K
Jun 3, 2026Klein Peter SDNLI
Award
19,226$0.00$0K
Jun 3, 2026FLATLEY JAY TDNLI
Award
6,408$0.00$0K
Jun 3, 2026Thornberry NancyDNLI
Award
19,226$0.00$0K
Jun 3, 2026Krognes Steve E.DNLI
Award
19,226$0.00$0K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.